XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Balance Sheets - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 17,468,088 $ 22,863,520
Deferred clinical supply costs 3,578,326 2,284,931
License fee and expense reimbursements receivable 429,006 1,183,786
Security deposits, current   119,550
Prepaid expenses and other current assets 1,801,373 1,190,719
Total Current Assets 23,276,793 27,642,506
Property and equipment, net 3,698,421 1,295,115
Security deposits, non-current 198,674 80,874
Operating lease right-of-use asset 1,915,061 1,291,592
Equipment deposits 257,950 726,326
Total Assets 29,346,899 31,036,413
Current Liabilities:    
Accounts payable 1,312,749 1,428,283
Accrued compensation 1,013,118 1,747,191
Accrued expenses and other current liabilities 363,431 503,076
Operating lease liabilities - current portion 427,749 484,882
Notes payable - current portion, net of debt discount of $91,621 and $33,885 as of June 30, 2023 and December 31, 2022, respectively 947,163 174,448
Convertible notes payable - current portoin, net of dedt discount of $0 and $33,885 as of June 30, 2023 and December 31, 2022, respectively   174,448
Total Current Liabilities 4,064,210 4,512,328
Operating lease liabilities - non-current portion 1,584,218 907,644
Notes payable - non-current portion, net of debt discount of $1,120,372 and $813,229 as of June 30, 2023 and December 31, 2022, respectively 8,683,794 4,190,938
Convertible notes payable - non-current portion, net of debt discount of $507,270 and $813,229 as of June 30, 2023 and December 31, 2022, respectively 4,492,730 4,190,938
Total Liabilities 18,824,952 13,801,848
Commitments and contingencies
Stockholders' Equity:    
Preferred stock, $0.0001 par value, 6,000,000 shares authorized; 0 shares issued and outstanding as of June 30, 2023 and December 31, 2022
Common stock, $0.0001 par value, 90,000,000 shares authorized; 38,169,398 and 36,668,980 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively 3,817 3,667
Additional paid-in capital 140,703,819 135,461,361
Accumulated deficit 130,185,689 118,230,463
Total Stockholders' Equity 10,521,947 17,234,565
Total Liabilities and Stockholders' Equity $ 29,346,899 $ 31,036,413